期刊文献+

复方川芎嗪治疗冠心病心绞痛50例的疗效 被引量:7

The efficacy of ligustrazine compound to control angina pectoris in the coronary heart disease in 50 patients
原文传递
导出
摘要 用复方川芎嗪微粒胶囊剂治疗50例冠心病心绞痛患者。结果总有效率75%,心电图总有效率56%;对心功能、血液流变学及血小板聚集率等均无影响;无明显副作用。该胶囊剂可作为治疗冠心病心绞痛的有效药物之一。 50 cases of CHD with angina pectoris received ligustrazine Co. capsule one piece qid for 4 wk as a course of treatment.The result of the total symptomatic release was 75% while the ECG improvement 56%.As the cardiac functions, hemorheological changes, aggregation rates of blood platelet and adverse reactions concerned there had no significant interferences been observed. It is therefore considered that this drug might be effective for those suffered from CHD with angina pectoris.
出处 《新药与临床》 CSCD 北大核心 1989年第3期146-148,共3页
关键词 复方川芎嗪 心绞痛 冠心病 ligustrazine Co coronary disease rheology angina pectoris
  • 相关文献

同被引文献53

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部